Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary
NCT03278600 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 182
Last updated 2022-01-24
Summary
This study is designed to evaluate the value of tissue-of-origin (ORIGIN-PanCA○R) profiling in predicting primary site and directing therapy in patients with cancer of unknown primary.
Conditions
- Cancer of Unknown Primary Site
Interventions
- GENETIC
-
tissue-of-origin (ORIGIN-PanCA○R) profiling
90-gene assay to predict the primary tumor site
Sponsors & Collaborators
-
Fudan University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-18
- Primary Completion
- 2021-03-18
- Completion
- 2021-03-18
Countries
- China
Study Locations
More Related Trials
-
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
NCT02279004 ·Status: ACTIVE_NOT_RECRUITING
-
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
NCT02628379 ·Status: COMPLETED
-
Role of Genomic Imprinting in Cancer Diagnosis
NCT03882684 ·Status: UNKNOWN
-
Epigenetic Regulation of Colorectal Polyps and Cancer
NCT06206603 ·Status: RECRUITING
-
Mutational Oncology in Clinical Practice
NCT06020625 ·Status: RECRUITING ·Phase: NA
-
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
NCT02215928 ·Status: RECRUITING
-
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT02688517 ·Status: RECRUITING
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Collection of Tissue Samples for Study of Multidrug Resistance
NCT00880503 ·Status: COMPLETED
-
Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer
NCT02610218 ·Status: UNKNOWN
-
Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer
NCT02671045 ·Status: TERMINATED
-
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
NCT03739827 ·Status: RECRUITING
-
GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers
NCT06076070 ·Status: UNKNOWN
-
Pan-tumor MRD Study
NCT06605404 ·Status: RECRUITING
-
Circulating Tumor DNA Exposure in Peripheral Blood
NCT03517332 ·Status: UNKNOWN
-
Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
NCT01703585 ·Status: COMPLETED
-
Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors
NCT02092714 ·Status: UNKNOWN
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Genomic Profiling Assay in Phase I
NCT02437617 ·Status: COMPLETED
-
Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors
NCT05847855 ·Status: RECRUITING
-
Evaluation of the Added Value of a Large Molecular Profiling Panel Versus a Limited Molecular Profiling Panel in Advanced Solid Tumors.
NCT03163732 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of Single Cell Mutations in a Panel of Known Oncogenes in NSCLC Surgical Specimens
NCT06050278 ·Status: RECRUITING
-
Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT
NCT04822792 ·Status: UNKNOWN
-
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
NCT03762733 ·Status: ENROLLING_BY_INVITATION
-
Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy
NCT06290856 ·Status: TERMINATED